-
+39 +1
FDA Approves Bayer's Electronic Autoinjector for MS Therapy
The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis received approval from the U.S. Food and Drug Administration on Friday.
-
+43 +1
Nigeria Wins Battle Against Polio: Here's How It Fought The Disease
The World Health Organization (WHO) said on Friday that Nigeria, which has long battled with polio, is no longer on the list of countries that spread the disease, a feat that brings the world closer to fully eliminating the disease. Since July last year, the African country has not reported new incidence of polio, an accomplishment that is attributed in part to intensified immunization drives.
-
+57 +1
The drug industry wants us to think Martin Shkreli is a rogue CEO. He isn’t.
Three millennia ago in ancient Greece, a plant called autumn crocus was used to treat gout. A pill form of the active ingredient, colchicine, has been used to treat the illness in the United States since the 19th century. But six years ago, a clinical trial showed the drug's safety and efficacy and URL Pharma was granted the exclusive marketing rights for a drug that had previously sold for 9 cents a tablet. The price shot up to $4.85 -- a more than 5,000 percent increase.
-
+21 +1
29th September 1982 - Cyanide-laced Tylenol kills six
Flight attendant Paula Prince buys a bottle of cyanide-laced Tylenol. Prince was found dead on October 1, becoming the final victim of a mysterious ailment in Chicago, Illinois. Over the previous 24 hours, six other people had suddenly died of unknown causes in northwest Chicago.
-
+47 +2
What the U.S. Can Learn From Brazil's Healthcare System
On a recent afternoon in Boa Vista, a lower-middle-class neighborhood of Sao Paulo, Brazil, Noranei Oliveira Miranda waited patiently on a small couch for the local community health workers to arrive. Her aging father, Dirceu, was seated next to her, not as patiently. Trembling and non-verbal, he reared up from the couch and reached in vain for the front door. She held him down with a pillow, her strong arms forming a seatbelt across his torso.
-
+3 +1
A World Without Cancer (and Obesity)
Before driving cross-country a few weeks ago, I happened to see that Amazon now offers free audio narration with many of their Kindle books that are part of their Kindle Unlimited program. The first book I tried out was simply mind-blowing—Dr. Margaret Cuomo’s 2012 book, A World Without Cancer. Dr. Cuomo is a radiologist, and sister of New York Governor Andrew Cuomo.
-
+24 +1
This study is forcing economists to rethink high-deductible health insurance
Perhaps higher deductibles don't lead to smarter shoppers but rather, in the long run, sicker patients.
-
+36 +1
How Doctors Take Women's Pain Less Seriously
Early on a Wednesday morning, I heard an anguished cry—then silence. I rushed into the bedroom and watched my wife, Rachel, stumble from the bathroom, doubled over, hugging herself in pain. “Something’s wrong,” she gasped. This scared me. Rachel’s not the type to sound the alarm over every pinch or twinge. She cut her finger badly once, when we lived in Iowa City, and joked all the way to Mercy Hospital as the rag wrapped around...
-
+29 +1
A Looming Tax On High-End Health Plans Draws Fire From Many Sides
A plan to tax high-value health insurance plans is meeting stiff resistance from both sides of the aisle in Congress
-
+33 +1
Why are placebos getting more effective?
Over the years the placebos used in drug trials have been getting more effective, especially in the US. Why?
-
+28 +1
Staggering Drug Price Hikes As High As 1,200% Driven By Hedge Funds, Activist Group Says
An analysis by Hedge Clippers, an activist group, found 19 drugs have experienced stunning price hikes of between 300 percent and 1,200 percent over the past two years.
-
+56 +1
Drug with rage-inducing 5,000% price-hike now has $1/pill competitor
Turing Pharmaceuticals, the company that last month raised the price of the decades-old drug Daraprim from $13.50 a pill to $750, now has a competitor. Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company based in San Diego, announced today that it has made an alternative to Daraprim that costs about a buck a pill—or $99 for a 100-pill supply.
-
Review-2 +1
Eli Lilly
Lilly makes medicines that help people live longer, healthier, more active lives. We were founded by Eli Lilly in 1876, and are now the 10th largest pharmaceutical company in the world. http://www.lilly.com
-
+20 +1
$750 Daraprim pill now has a $1 generic alternative | Toronto Star
Small U.S. firm that makes drugs to order has stepped into the furor launched by former hedge fund manager Martin Shkreli, whose firm has been buying rights to old drugs and raising their price manyfold.
-
+34 +1
Amgen wins EU green light for first virus-based cancer drug
A first-in-class drug from Amgen based on a tumour-killing virus was given a green light by European regulators on Friday, paving the way for its approval within a couple of months. The decision is a further milestone for a technology that has long fascinated scientists but has previously proved difficult to harness.
-
+28 +1
Red states spent $2 billion in 2015 to screw the poor
Medicaid funding is shared by the states and the federal government. Between 2000 and 2013—the most recent year reported by the CMS actuaries—the share of Medicaid spending shouldered by the states increased by an average of 6.1 percent per year. This is not total spending. It's just the portion the states themselves paid for.
-
+25 +1
We Mapped the Uninsured. You'll Notice a Pattern.
Two years into Obamacare, clear regional patterns are emerging about who has health insurance in America and who still doesn’t. They tend to live in the South, and they tend to be poor.
-
+35 +1
Battle over 'Cadillac tax' heats up
Every major presidential candidate has pledged to repeal the tax.
-
+41 +1
Last Week Tonight with John Oliver: Medicaid Gap (HBO)
The election in 2016 decides our new president, but the one this year could determine whether many Americans will have healthcare.
-
+19 +1
Death Rates Rising for Middle-Aged White Americans, Study Finds
Something startling is happening to middle-aged white Americans. Unlike every other age group, unlike every other racial and ethnic group, unlike their counterparts in other rich countries, death rates in this group have been rising, not falling. That finding was reported Monday by two Princeton economists, Angus Deaton, who last month won the 2015 Nobel Memorial Prize in for Economic Science, and Anne Case. Analyzing health and mortality data...
Submit a link
Start a discussion